👀 Trusting Our Children to the Worst Capital Allocator
Plus: THIS Biotech Has Major Catalysts on the Horizon, Is AI About to Be Dethroned?, and More
This week’s market, investing, and business insights from insiders and experts outside the mainstream media:
Incinerating our tax dollars with public schools.
THIS Biotech found a way to mimic exercise, no gym.
Is AI about to be dethroned?
Zuck’s Threads continues to quietly grow.
And more. Let’s get to it!
Follow us on Instagram | Advertise to our 7K+ subscribers
Top Insights of the Week
1. 👀 Trusting Our Children to the Worst Capital Allocator
Biden’s $42B broadband program hasn't connected a single home, and $7.5B for EV chargers has built only seven stations. WTF is going on? One word, bureaucracy. It incinerates tax dollars and sucks the life out of anything it touches. Now, its reached our public schools…
2000 to 2021, school administrators surged 95%! Students only 5%.
The math ain’t mathing, literally. Resources meant for students and teachers are funding layers of management, while academic results fall short.
Math scores flatlined since 2013, dropped between 2019-2022.
This needs to stop. One solution gaining traction...Alternative schooling.
IMG Academy, has produced many Olympic and pro athletes.
The School of Entrepreneuring, emphasizes entrepreneurship and creativity.
Astra Nova School, created at SpaceX.
Microschools, small schools in places like libraries and churches.
Proof School, core focus on problem solving and communication.
Digital Education (includes alternative schooling) market: ~$19B in 2023, projected ~$66B by 2028.
2. 😯 THIS Biotech Has Major Catalysts on the Horizon
The older you get, the harder it is to exercise and maintain muscle. Shoot, by age 30, even sneezing too hard made my body spaz out. Well, what if you could mimic all the same benefits of exercise without breaking a sweat? This company pulled it off—and they have the data to back it up…BioAge Labs, one drug in particular…
Reasons we’re paying attention…
Recently IPO, raised ~$200M to fund advanced trials.
Prior to IPO, raised ~$320M from top investors.
Accumulated 50 years of human data to target aging.
Developing another drug, BGE-100, to tackle brain diseases.
Other anti-aging related biotechs on our radar…
Google’s AlphaFold 3, potential to reverse aging and target cancer cells.
EvolutionaryScale, anti-aging treatments and faster/cheaper drug discovery.
Altos Labs received $3B to research a way to make cells younger.
Anew Medical, Klotho gene therapy to fight Parkinson and Alzheimer.
Anti-aging market: ~$73B in 2024, projected ~$140B by 2034.
3. 💸 Ready to get serious about investing?
Then join our growing list of premium subscribers who have already placed themselves on the path to greater wealth by mirroring our stock ideas.
Subscribe today for just $9/month.
🚨 What you get when you become a premium subscriber ($13,890.80 value) 🚨
TOP 5 MARKET BEATING STOCK IDEAS ($5,000 value) picked with sniper precision, delivered to your inbox every Monday morning, before the market opens.
HIGH CONVICTION TRADE ALERTS ($1,690.80 value) throughout the week as we spot them.
Access to OUR COMMUNITY ($1,200 value) of fellow traders, where you can ask questions & post comments.
END OF THE MONTH SUMMARY ($600 value) of which ideas performed best.
NO GUESSWORK ($2,400 value). You'll get to see our entry point, stop loss, and profit target.
INSTANT ACCESS, no strings attached. No commitment. Cancel anytime.
UNCONVENTIONAL MARKET & MACRO INSIGHTS ($3,000 value), discover opportunities and risks not highlighted elsewhere.
MAKE MONEY or GET YOUR MONEY BACK GUARANTEE. If you subscribe today, use it actively for a year, and don't make money, we'll refund your payment and give you an extra year for free.
Get $13,890.80 worth of value for just $9/month to our premium newsletter. Hands down, Money Machine Newsletter is the most valuable investing service out there.
4. 👑 Is AI About to Be Dethroned?
You get an AI model! You get an AI model! You get an AI model! I can hear Oprah in my head right now. It’s only a matter of time before AI models become as common as apps on your phone. So, who will be the real winner? Intellectual Property (IP).
Mayo Clinic is a great example. They’re not handing their data to big tech—it’s their edge. Instead, they've teamed up with two AI companies to work on cancer care and predictive health, building their own AI models.
Aiforia, working on AI models to predict colorectal cancer recurrence.
SimBioSys, developing AI tools for personalized breast cancer treatment.
Launched two new companies—Anumana and Lucem Health. Both use AI and patient data to prevent dangerous irregular heartbeats.
An interesting counterpoint to IP in AI is synthetic data (fake data instead of real-world data). While it helps, it still needs careful validation. For now, IP is king.
OpenAI, accused of copyright violations for training AI.
AI music generators Suno and Udio sued for copyright infringement.
A few startups are seeing this as an opportunity…
Community Spotlight
Newsletters from other independent thinkers you might find interesting.
👉 Liberty and Tea, weekly newsletter discussing life, liberty, and the pursuit of happiness.
👉 Panic Drop, learn to profit from market panic and master the art of combining stocks with crypto!
👉 Bitcoin Fortress Newsletter, empowering your journey towards financial freedom through the lens of Bitcoin wisdom.
👉 ThirdSpace Buzz, unlock your entrepreneurial potential: a newsletter for visionaries, innovators, and leaders.
Top 3 Charts of the Week
1. 📈 Threads Traffic Continues to Grow
Threads got 21.7M (according to similarweb.com) U.S. visits in September, its best since launch, but it's still far behind Twitter (X).
Threads is growing, but engagement issues like "rage bait" are holding it back.
Threads could potentially become a Twitter alternative.
2. 👨💼 U.S. Job Market Keeps Ticking Along
U.S. added 254,000 jobs in September, much more than expected.
The economy is doing better than predicted, making a big rate cut less likely.
A strong job market helps stocks go up but may keep borrowing costs higher.
3. 🚙 Waymo Logs Millions of Miles in Autonomous Vehicle Testing
Waymo has 700 robotaxis, 100,000 weekly rides, and 4.9M miles logged in 2023.
Waymo proves robotaxis work, but 93% of people still don’t trust them.
What did you think of today’s newsletter?
Enjoy this content? Subscribe to our Instagram
We take the responsibility of emailing you seriously. If you don't want to receive stock market updates and trading education anymore, you can unsubscribe at any time.
Nothing in this email is intended to serve as financial advice. Do your own research. See important disclaimer & terms of service.